Phase 4RecruitingHealthspan endpoint
Personalized Analgesia Through Central Nervous System Engagement to Unlock Performance (PACE-UP)
- Sponsor
- Benedict Alter (Academic or other)
- Enrollment
- 85 planned
- Conditions
- Knee Osteoarthritis (Knee OA); Chronic Pain; Chronic Knee Pain
- Interventions
- Duloxetine; Placebo
- Ages
- adults, older adults
- Registry
- NCT07759336
Full record on ClinicalTrials.gov
From the registry
The goal of this clinical trial is to examine the effects of duloxetine on walking ability and physical activity in patients with knee osteoarthritis. Researchers will compare duloxetine to a placebo (a look-alike substance that contains no drug) to see if duloxetine works to improve walking ability in patients with knee osteoarthritis. At study visits, participants will complete surveys, perform physical function tasks, undergo non-invasive brain imaging, and undergo sensory testing.
Primary outcomes
- Distance walked in the 6-minute walking test
History
Study completion expected
Primary completion expected
Last registry update
Started
Registered